Stocks
Alnylam Pharmaceuticals (ALNY) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -14.2 | -17.4 | -23.6 | -25.6 | -54.3 | -280.7 | ||
| Changes by years, y/y, % | +47% | +23% | +35% | +9% | +112% | +41.3% | |||
Alnylam Pharmaceuticals. P/E
Alnylam Pharmaceuticals. P/E, changes, %
Alnylam Pharmaceuticals (ALNY) P/E US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| P/E | ? | -22.3 | -43.5 | -54.6 | -56.8 | -422.2 | -280.7 | |
| Changes by years, y/y, % | +24% | +110% | +111% | +143% | +1 796% | |||
| Changes by quarters, q/q, % | -5% | +95% | +26% | +4% | +644% | |||
